Form 4: Medifast Director Elizabeth Geary Receives 11,168 Restricted Stock Units as Annual Compensation

Medifast, Inc. Director Elizabeth A. Geary was granted 11,168 restricted stock units as part of her annual director fees, aligning her interests with shareholders.

Summary

• Elizabeth A. Geary, a Director at Medifast, Inc. (MED), acquired 11,168 shares of common stock in the form of restricted stock units (RSUs) on June 25, 2025.
• These RSUs were granted at a price of $0 per unit, representing compensation for her annual director fees.
• The grant was made under the Medifast, Inc. Director's Deferred Compensation Plan, as Amended and Restated, and sourced from the Issuer's Amended and Restated 2012 Share Incentive Plan.
• Each RSU represents the right to receive one share of Medifast common stock.
• The acquired RSUs are scheduled to vest in full on June 25, 2026.
• Following this transaction, Ms. Geary beneficially owns a total of 19,545 shares of Medifast common stock.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as the RSU grant aligns director interests with shareholders, which is generally viewed favorably. However, it's a routine compensation event and not indicative of significant operational or financial news.

Positives

• The grant of restricted stock units to a director aligns management and board interests with those of shareholders, as the value of the compensation is tied to the company's stock performance.
• This transaction represents a routine and expected form of non-cash compensation for board service, indicating stable corporate governance practices.

Future Outlook

The document does not provide a general future outlook for the company, focusing solely on an insider transaction.

Industry Context

The granting of restricted stock units to directors as part of their compensation is a common practice across various industries, including the health and wellness sector where Medifast operates. This method of compensation is widely used to incentivize long-term commitment and align the interests of board members with shareholder value creation.

Comparison to Industry Standards

• The practice of compensating directors with equity, such as restricted stock units, is a standard corporate governance practice observed across publicly traded companies globally, including those in the consumer health and direct selling industries.
• Companies like Herbalife Nutrition Ltd. (HLF) and WW International, Inc. (WW) also utilize equity-based compensation plans for their directors and executives to foster alignment with shareholder interests, making Medifast's approach consistent with industry norms.

Related Party Transactions

• The grant of 11,168 restricted stock units to Elizabeth A. Geary, a Director of Medifast, Inc., constitutes a related party transaction as it involves compensation provided by the company to a member of its board of directors.

Stakeholder Impact

• Shareholders: The equity grant to a director helps align the director's financial interests with those of the shareholders, potentially encouraging decisions that enhance long-term shareholder value.

Next Steps

• The 11,168 restricted stock units granted to Director Elizabeth A. Geary are scheduled to vest in full on June 25, 2026.

Key Dates

Keywords

Medifast, MED, Form 4, Director Compensation, Restricted Stock Units, RSU Grant, Insider Transaction, Equity Compensation, Corporate Governance